LALPATHLAB.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 18:00):

Stats
今日成交量	70 861.00
平均成交量	254 323
市值	194.04B
EPS	INR0 ( 2024-02-01 )
下一个收益日期	( INR6.03 ) 2024-05-08
Last Dividend	INR12.00 ( 2023-08-11 )
Next Dividend	INR0 ( N/A )
P/E	59.05
ATR14	INR2.80 (0.12%)

音量相关性

長: 0.02 (neutral)

短: -0.71 (moderate negative)

Signal:(58.914) Neutral

Dr. Lal PathLabs Limited 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Dr. Lal PathLabs Limited 相关性 - 货币/商品

-0.08
( neutral )

0.03
( neutral )

0.02
( neutral )

-0.19
( neutral )

-0.49
( neutral )

0.04
( neutral )

Dr. Lal PathLabs Limited 财务报表

Annual	2022
营收:	INR20.17B
毛利润:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
营收:	INR20.17B
毛利润:	INR15.70B (77.83 %)
EPS:	INR28.82

FY	2022
营收:	INR20.87B
毛利润:	INR13.00B (62.31 %)
EPS:	INR41.70

FY	2021
营收:	INR15.81B
毛利润:	INR11.84B (74.88 %)
EPS:	INR35.33

Financial Reports:

No articles found.

Dr. Lal PathLabs Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR6.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR12.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Dr. Lal PathLabs Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.87 - low (50.00%) | Divividend Growth Potential Score: 3.10 - Decrease likely (37.98%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.45	2016-07-20
Last Dividend	INR12.00	2023-08-11
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR77.95	--
Avg. Dividend % Per Year	0.37%	--
Score	2.2	--
Div. Sustainability Score	2.87
Div.Growth Potential Score	3.10
Div. Directional Score	2.99	--

Next Divdend (Est)
(2024-06-10)

INR13.50 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

2.20

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR5.50	0.66%
2019	INR9.50	1.03%
2020	INR12.00	0.78%
2021	INR20.00	0.83%
2022	INR12.00	0.31%
2023	INR12.00	0.55%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
STARPAPER.NS	Dividend Junior	2023-09-15	Sporadic	22	1.19%
MUNJALAU.NS	Dividend Junior	2023-08-24	Sporadic	19	1.47%
HINDCOMPOS.NS	Dividend Junior	2023-09-22	Annually	23	0.50%
BODALCHEM.NS	Dividend Junior	2023-09-22	Annually	14	0.38%
RELAXO.NS	Dividend Junior	2023-08-17	Annually	14	0.17%
KRBL.NS	Dividend Junior	2023-08-25	Annually	23	0.61%
FCL.NS	Dividend Junior	2023-09-08	Annually	10	0.22%
ANANTRAJ.NS	Dividend Junior	2023-06-27	Annually	18	0.22%
TATACOFFEE.NS	Dividend Junior	2023-05-15	Annually	23	0.85%
NIACL.NS	No Dividend Player	2023-09-07	Sporadic	7	0.44%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.152	1.500	6.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.190	1.500	9.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	15.29	1.000	5.45	5.45	[3 - 30]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
freeCashFlowPerShareTTM	28.46	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.684	1.000	1.929	1.929	[0.2 - 0.8]
operatingProfitMarginTTM	0.224	1.000	7.52	7.52	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.87

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	58.65	1.000	4.18	0	[1 - 100]
returnOnEquityTTM	0.190	2.50	9.36	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	28.46	2.00	0.514	10.00	[0 - 30]
dividendYielPercentageTTM	1.032	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	28.46	2.00	0.514	1.028	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.109	1.000	9.77	0	[0.1 - 0.5]
Total Score				3.10

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.

实时更新： Dr. Lal PathLabs Limited [LALPATHLAB.NS]

Upcoming Earnings Alert

Dr. Lal PathLabs Limited Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)